accessibility menu, dialog, popup

UserName
Viewing profile as user:

Tosyl compounds

Organic compounds that consist of a toluene molecule with a sulfonyl group substitution; a sulfonyl group consists of a sulfur atom bonded to two oxygen atoms via double bonds. A toluene molecule is a benzene with a methyl group substitution.

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (4)

special interests

  • (4)
Search Within Results
Keyword Search:
1 – 4 of 4 results
1

Medchemexpress LLC Lansoprazole sulfone | 131926-99-3 | 99.5% | 385.36 | 50 MG
SDP

Lansoprazole sulfone (AG-1813) is an orally active and selective inhibitor of H+, K+-ATPase. It significantly stimulates gastric acid secretion by inhibiting H+, K+-ATPase. This compound has potential applications in various gastrointestinal conditions.

  • Orally active and selective inhibitor of H+, K+-ATPase.
  • Significantly stimulates gastric acid secretion through H+, K+-ATPase inhibition.
  • Potential applications include duodenal ulcer, gastric ulcer, gastroesophageal reflux disease, and Zolinger Ellison disease.

ENCOMPASS_PREFERRED
2

Medchemexpress LLC Lansoprazole sulfone | 131926-99-3 | 99.5% | 385.36 | 10 MG
SDP

Lansoprazole sulfone (AG-1813) is an orally active and selective inhibitor of H+, K+-ATPase. It significantly stimulates gastric acid secretion by inhibiting H+, K+-ATPase. This compound has potential applications in treating various gastrointestinal conditions.

  • Orally active
  • Selective H+, K+-ATPase inhibitor
  • Stimulates gastric acid secretion
  • Potential application in duodenal ulcer
  • Potential application in gastric ulcer
  • Potential application in gastroesophageal reflux disease
  • Potential application in Zollinger-Ellison disease

ENCOMPASS_PREFERRED
3

Medchemexpress LLC Lansoprazole sulfone | 131926-99-3 | 99.5% | 385.36 | 100 MG
SDP

Lansoprazole sulfone (AG-1813) is an orally active and selective inhibitor of H+, K+-ATPase. It significantly stimulates gastric acid secretion by inhibiting H+, K+-ATPase. It has potential applications in duodenal ulcer, gastric ulcer, gastroesophageal reflux disease, and Zollinger-Ellison disease. It is for research use only and not sold to patients.

  • Orally active and selective inhibitor of H+, K+-ATPase.
  • Significantly stimulates gastric acid secretion by inhibiting H+, K+-ATPase.
  • Potential applications in duodenal ulcer, gastric ulcer, gastroesophageal reflux disease, and Zollinger-Ellison disease.

ENCOMPASS_PREFERRED
4

Medchemexpress LLC Lansoprazole sulfone | 131926-99-3 | 99.52% | 385.36 | 25 MG
SDP

Lansoprazole sulfone (AG-1813) is an orally active and selective inhibitor of H+, K+-ATPase. It significantly stimulates gastric acid secretion by inhibiting H+, K+-ATPase. This product has potential applications in treating duodenal ulcer, gastric ulcer, gastroesophageal reflux disease, and Zollinger-Ellison disease. It is for research use only and not sold to patients.

  • Orally active and selective H+, K+-ATPase inhibitor.
  • Significantly stimulates gastric acid secretion by inhibiting H+, K+-ATPase.
  • Potential applications in duodenal ulcer, gastric ulcer, gastroesophageal reflux disease, and Zollinger-Ellison disease.

ENCOMPASS_PREFERRED